KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Other financing activities (2019 - 2025)

ClearPoint Neuro's Other financing activities history spans 5 years, with the latest figure at $2.0 million for Q3 2025.

  • For Q3 2025, Other financing activities rose 3214.75% year-over-year to $2.0 million; the TTM value through Sep 2025 reached $3.0 million, up 32.38%, while the annual FY2024 figure was $424000.0, 93.03% down from the prior year.
  • Other financing activities for Q3 2025 was $2.0 million at ClearPoint Neuro, up from $356000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $2.0 million in Q3 2025 and bottomed at -$1.3 million in Q4 2024.
  • The 3-year median for Other financing activities is $338000.0 (2021), against an average of $586300.0.
  • The largest annual shift saw Other financing activities increased 2.49% in 2021 before it skyrocketed 3214.75% in 2025.
  • A 3-year view of Other financing activities shows it stood at $586000.0 in 2021, then crashed by 316.55% to -$1.3 million in 2024, then surged by 259.34% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Other financing activities are $2.0 million (Q3 2025), $356000.0 (Q2 2025), and $1.9 million (Q1 2025).